Pembelian
Idea about Aerie Pharmaceuticals
Aerie Pharmaceuticals is a pharmaceutical company dedicated to developing treatments for glaucoma and other eye conditions. Founded in 2005. Revenue $ 83 million (2020). Capitalization $ 489 million
Medium-term trade following a trend. The low of the candlestick at $ 9.68 formed a support level upon a repeated approach to the base of the trend reversal.
The reference point for the target is the level formed by the maximum of the trend reversal candle of the previous local maximum.
Long $ 10.28
Goal: $ 12.1
Stop below $ 9.9
NOT IRR.
Medium-term trade following a trend. The low of the candlestick at $ 9.68 formed a support level upon a repeated approach to the base of the trend reversal.
The reference point for the target is the level formed by the maximum of the trend reversal candle of the previous local maximum.
Long $ 10.28
Goal: $ 12.1
Stop below $ 9.9
NOT IRR.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.